Related links
Allergy Drug Improves Function in Patients with Chronic Injury ...
Oct 10, 2017 — UCSF scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system ...
Learn more
Cotton wool spots - Wikipedia
, also known by its brand name Mavenclad, is a purine antimetabolite and antineoplastic drug used to reduce relapse rates and slow down disease
Learn more
FDA approves new oral treatment for multiple sclerosis
Mar 29, 2019 The U.S. Food and Drug Administration today approved Mavenclad () tablets to treat relapsing forms of multiple sclerosis (MS) in
Learn more